Figure 3
From: High-level JAG1 mRNA and protein predict poor outcome in breast cancer
Relationship between combined JAG1 mRNA and protein levels and overall survival in patients with breast cancer. (a) Patients with tumors expressing low levels of JAG1 mRNA and protein had a 10-year survival of 53% and median survival of 131 months (—). (b) Patients with tumors expressing high levels of JAG1 mRNA and protein had a 10-year survival of 11% and median survival of 23 months (- - -). The value of adding protein data to predict outcome was exclusive to the JAG1 mRNA low group (interaction P=0.055).
